Federal Register of Legislation - Australian Government

Primary content

PB 90 of 2011 Determinations/Health as made
This Determination amends the National Health (Listed Drugs on F1 or F2) Determination 2010 (No. PB 93 of 2010) to provide for allocation of drugs to the F1 and F2 formularies for the Pharmaceutical Benefits Scheme.
Administered by: Health
Registered 29 Nov 2011
Tabling HistoryDate
Tabled HR07-Feb-2012
Tabled Senate07-Feb-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.12)

Instrument number PB 90 of 2011

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated                 24               November   2011

 

 

 

 

 

 

 

 

 

ADRIANA PLATONA

 

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

 

 

Part 1         Preliminary

1              Name of Determination

         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.12).

         (2)   This Determination may also be cited as PB 90 of 2011.

2              Commencement

                This Determination commences on 1 December 2011.

3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).


Schedule 1             Amendments

 

(Section 3)

 

 

[1]     Schedule 1, after item dealing with Atazanavir

 

Insert

 

Asenapine 

 

[2]     Schedule 1, after item dealing with Colestipol

 

Insert

 

Corifollitropin alfa 

 

 

[3]     Schedule 1, after item dealing with Desvenlafaxine

 

Omit

 

Dexamethasone 

 

[4]     Schedule 1, after item dealing with Imiquimod

 

Insert

 

Indacaterol 

 

 

[5]     Schedule 1, after item dealing with Lithium

 

Insert

 

Losartan 

 

[6]     Schedule 1, after item dealing with Maraviroc

 

Insert

 

Magnesium 

 

[7]     Schedule 1, after item dealing with Telmisartan

 

Omit

 

Temozolomide 

 

 

 

 

[8]     Schedule 1, after item dealing with Thioguanine

 

Omit

 

Thiotepa 

 

 

[9]     Schedule 2, after item dealing with Desferrioxamine

 

Insert

 

Dexamethasone 

 

 

[10]   Schedule 2, after item dealing with Temazepam

 

Insert

 

Temozolomide 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.